For patients with significant joint damage, tirzepatide is often most useful as a foundation alongside regenerative treatments like PRP or a broader pain management plan improving the terrain so targeted treatments work better
Mak DH, Schober WD, Chen W, Cortes JE, Kantarjian HM, Andreeff M , Carter BZ
This has not been done for retatrutide or any GLP-1 receptor agonist in employment or general drug testing contexts
Qualified researchers may submit a request containing the research objectives, the Amgen product(s) and Amgen study/studies in scope, end points/outcomes of interest, statistical analysis plan, data requirements, publication plan and qualifications of the researcher(s)